APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pregabalin

Compare research editions
View pricing & licenses

Selected research

Industry Research

Pregabalin Industry Research Report 2026

19 December 2025143 pages

Choose your research edition.

Industry ResearchPregabalin Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Pregabalin Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Pregabalin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pregabalin Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Pregabalin Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Pregabalin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Pregabalin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Pregabalin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Pregabalin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Pregabalin include Zhejiang Huahai Pharmaceutical, Teva Pharmaceutical Industries, Sun Pharmaceutical Industries, Changzhou Pharmaceutical Factory (CPF), ZCL Chemicals, Vasudha Pharma Chem, Srini Pharmaceuticals, Olon S.p.A. and Maps Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Pregabalin market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Pregabalin Market by Company

Zhejiang Huahai Pharmaceutical

Teva Pharmaceutical Industries

Sun Pharmaceutical Industries

Changzhou Pharmaceutical Factory (CPF)

ZCL Chemicals

Vasudha Pharma Chem

Srini Pharmaceuticals

Olon S.p.A.

Maps Laboratories

Laurus Labs

Hikal

Glenmark Life Sciences

Dongbang FTL

Divi’s Laboratories

Divi’s Laboratories

CTX Life Sciences

Chemo Iberica

Bazayan

BAL Pharma

Aurobindo Pharma

ARITE Pharmaceutical

Angels Pharma

Almelo Pvt. Ltd.

AASraw Biochemical Technology

Pregabalin Segment by Type

Capsule

Oral Solution

Tablet

Pregabalin Segment by Application

Hospitals

Clinics

Others

Pregabalin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pregabalin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pregabalin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pregabalin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Pregabalin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Pregabalin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Pregabalin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pregabalin Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Pregabalin Sales (W Units) of Manufacturers (2021-2026) Table 7. Global Pregabalin Sales Market Share by Manufacturers (2021-2026) Table 8. Global Pregabalin Revenue of Manufacturers (2021-2026) Table 9. Global Pregabalin Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Pregabalin Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Pregabalin Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Pregabalin, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Pregabalin, Product Type & Application Table 14. Global Pregabalin Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Pregabalin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Zhejiang Huahai Pharmaceutical Company Information Table 19. Zhejiang Huahai Pharmaceutical Business Overview Table 20. Zhejiang Huahai Pharmaceutical Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Zhejiang Huahai Pharmaceutical Pregabalin Product Portfolio Table 22. Zhejiang Huahai Pharmaceutical Recent Developments Table 23. Teva Pharmaceutical Industries Company Information Table 24. Teva Pharmaceutical Industries Business Overview Table 25. Teva Pharmaceutical Industries Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Teva Pharmaceutical Industries Pregabalin Product Portfolio Table 27. Teva Pharmaceutical Industries Recent Developments Table 28. Sun Pharmaceutical Industries Company Information Table 29. Sun Pharmaceutical Industries Business Overview Table 30. Sun Pharmaceutical Industries Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Sun Pharmaceutical Industries Pregabalin Product Portfolio Table 32. Sun Pharmaceutical Industries Recent Developments Table 33. Changzhou Pharmaceutical Factory (CPF) Company Information Table 34. Changzhou Pharmaceutical Factory (CPF) Business Overview Table 35. Changzhou Pharmaceutical Factory (CPF) Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Changzhou Pharmaceutical Factory (CPF) Pregabalin Product Portfolio Table 37. Changzhou Pharmaceutical Factory (CPF) Recent Developments Table 38. ZCL Chemicals Company Information Table 39. ZCL Chemicals Business Overview Table 40. ZCL Chemicals Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. ZCL Chemicals Pregabalin Product Portfolio Table 42. ZCL Chemicals Recent Developments Table 43. Vasudha Pharma Chem Company Information Table 44. Vasudha Pharma Chem Business Overview Table 45. Vasudha Pharma Chem Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Vasudha Pharma Chem Pregabalin Product Portfolio Table 47. Vasudha Pharma Chem Recent Developments Table 48. Srini Pharmaceuticals Company Information Table 49. Srini Pharmaceuticals Business Overview Table 50. Srini Pharmaceuticals Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Srini Pharmaceuticals Pregabalin Product Portfolio Table 52. Srini Pharmaceuticals Recent Developments Table 53. Olon S.p.A. Company Information Table 54. Olon S.p.A. Business Overview Table 55. Olon S.p.A. Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Olon S.p.A. Pregabalin Product Portfolio Table 57. Olon S.p.A. Recent Developments Table 58. Maps Laboratories Company Information Table 59. Maps Laboratories Business Overview Table 60. Maps Laboratories Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Maps Laboratories Pregabalin Product Portfolio Table 62. Maps Laboratories Recent Developments Table 63. Laurus Labs Company Information Table 64. Laurus Labs Business Overview Table 65. Laurus Labs Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Laurus Labs Pregabalin Product Portfolio Table 67. Laurus Labs Recent Developments Table 68. Hikal Company Information Table 69. Hikal Business Overview Table 70. Hikal Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Hikal Pregabalin Product Portfolio Table 72. Hikal Recent Developments Table 73. Glenmark Life Sciences Company Information Table 74. Glenmark Life Sciences Business Overview Table 75. Glenmark Life Sciences Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Glenmark Life Sciences Pregabalin Product Portfolio Table 77. Glenmark Life Sciences Recent Developments Table 78. Dongbang FTL Company Information Table 79. Dongbang FTL Business Overview Table 80. Dongbang FTL Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Dongbang FTL Pregabalin Product Portfolio Table 82. Dongbang FTL Recent Developments Table 83. Divi’s Laboratories Company Information Table 84. Divi’s Laboratories Business Overview Table 85. Divi’s Laboratories Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Divi’s Laboratories Pregabalin Product Portfolio Table 87. Divi’s Laboratories Recent Developments Table 88. Divi’s Laboratories Company Information Table 89. Divi’s Laboratories Business Overview Table 90. Divi’s Laboratories Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Divi’s Laboratories Pregabalin Product Portfolio Table 92. Divi’s Laboratories Recent Developments Table 93. CTX Life Sciences Company Information Table 94. CTX Life Sciences Business Overview Table 95. CTX Life Sciences Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. CTX Life Sciences Pregabalin Product Portfolio Table 97. CTX Life Sciences Recent Developments Table 98. Chemo Iberica Company Information Table 99. Chemo Iberica Business Overview Table 100. Chemo Iberica Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Chemo Iberica Pregabalin Product Portfolio Table 102. Chemo Iberica Recent Developments Table 103. Bazayan Company Information Table 104. Bazayan Business Overview Table 105. Bazayan Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Bazayan Pregabalin Product Portfolio Table 107. Bazayan Recent Developments Table 108. BAL Pharma Company Information Table 109. BAL Pharma Business Overview Table 110. BAL Pharma Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. BAL Pharma Pregabalin Product Portfolio Table 112. BAL Pharma Recent Developments Table 113. Aurobindo Pharma Company Information Table 114. Aurobindo Pharma Business Overview Table 115. Aurobindo Pharma Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Aurobindo Pharma Pregabalin Product Portfolio Table 117. Aurobindo Pharma Recent Developments Table 118. ARITE Pharmaceutical Company Information Table 119. ARITE Pharmaceutical Business Overview Table 120. ARITE Pharmaceutical Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. ARITE Pharmaceutical Pregabalin Product Portfolio Table 122. ARITE Pharmaceutical Recent Developments Table 123. Angels Pharma Company Information Table 124. Angels Pharma Business Overview Table 125. Angels Pharma Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Angels Pharma Pregabalin Product Portfolio Table 127. Angels Pharma Recent Developments Table 128. Almelo Pvt. Ltd. Company Information Table 129. Almelo Pvt. Ltd. Business Overview Table 130. Almelo Pvt. Ltd. Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Almelo Pvt. Ltd. Pregabalin Product Portfolio Table 132. Almelo Pvt. Ltd. Recent Developments Table 133. AASraw Biochemical Technology Company Information Table 134. AASraw Biochemical Technology Business Overview Table 135. AASraw Biochemical Technology Pregabalin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. AASraw Biochemical Technology Pregabalin Product Portfolio Table 137. AASraw Biochemical Technology Recent Developments Table 138. Global Pregabalin Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 139. Global Pregabalin Sales by Region (2021-2026) & (W Units) Table 140. Global Pregabalin Sales Market Share by Region (2021-2026) Table 141. Global Pregabalin Sales by Region (2027-2032) & (W Units) Table 142. Global Pregabalin Sales Market Share by Region (2027-2032) Table 143. Global Pregabalin Revenue by Region (2021-2026) & (US$ Million) Table 144. Global Pregabalin Revenue Market Share by Region (2021-2026) Table 145. Global Pregabalin Revenue by Region (2027-2032) & (US$ Million) Table 146. Global Pregabalin Revenue Market Share by Region (2027-2032) Table 147. North America Pregabalin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. North America Pregabalin Sales by Country (2021-2026) & (W Units) Table 149. North America Pregabalin Sales by Country (2027-2032) & (W Units) Table 150. North America Pregabalin Revenue by Country (2021-2026) & (US$ Million) Table 151. North America Pregabalin Revenue by Country (2027-2032) & (US$ Million) Table 152. Europe Pregabalin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Europe Pregabalin Sales by Country (2021-2026) & (W Units) Table 154. Europe Pregabalin Sales by Country (2027-2032) & (W Units) Table 155. Europe Pregabalin Revenue by Country (2021-2026) & (US$ Million) Table 156. Europe Pregabalin Revenue by Country (2027-2032) & (US$ Million) Table 157. Asia Pacific Pregabalin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. Asia Pacific Pregabalin Sales by Country (2021-2026) & (W Units) Table 159. Asia Pacific Pregabalin Sales by Country (2027-2032) & (W Units) Table 160. Asia Pacific Pregabalin Revenue by Country (2021-2026) & (US$ Million) Table 161. Asia Pacific Pregabalin Revenue by Country (2027-2032) & (US$ Million) Table 162. South America Pregabalin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. South America Pregabalin Sales by Country (2021-2026) & (W Units) Table 164. South America Pregabalin Sales by Country (2027-2032) & (W Units) Table 165. South America Pregabalin Revenue by Country (2021-2026) & (US$ Million) Table 166. South America Pregabalin Revenue by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Pregabalin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 168. Middle East and Africa Pregabalin Sales by Country (2021-2026) & (W Units) Table 169. Middle East and Africa Pregabalin Sales by Country (2027-2032) & (W Units) Table 170. Middle East and Africa Pregabalin Revenue by Country (2021-2026) & (US$ Million) Table 171. Middle East and Africa Pregabalin Revenue by Country (2027-2032) & (US$ Million) Table 172. Global Pregabalin Sales by Type (2021-2026) & (W Units) Table 173. Global Pregabalin Sales by Type (2027-2032) & (W Units) Table 174. Global Pregabalin Sales Market Share by Type (2021-2026) Table 175. Global Pregabalin Sales Market Share by Type (2027-2032) Table 176. Global Pregabalin Revenue by Type (2021-2026) & (US$ Million) Table 177. Global Pregabalin Revenue by Type (2027-2032) & (US$ Million) Table 178. Global Pregabalin Revenue Market Share by Type (2021-2026) Table 179. Global Pregabalin Revenue Market Share by Type (2027-2032) Table 180. Global Pregabalin Price by Type (2021-2026) & (US$/Unit) Table 181. Global Pregabalin Price by Type (2027-2032) & (US$/Unit) Table 182. Global Pregabalin Sales by Application (2021-2026) & (W Units) Table 183. Global Pregabalin Sales by Application (2027-2032) & (W Units) Table 184. Global Pregabalin Sales Market Share by Application (2021-2026) Table 185. Global Pregabalin Sales Market Share by Application (2027-2032) Table 186. Global Pregabalin Revenue by Application (2021-2026) & (US$ Million) Table 187. Global Pregabalin Revenue by Application (2027-2032) & (US$ Million) Table 188. Global Pregabalin Revenue Market Share by Application (2021-2026) Table 189. Global Pregabalin Revenue Market Share by Application (2027-2032) Table 190. Global Pregabalin Price by Application (2021-2026) & (US$/Unit) Table 191. Global Pregabalin Price by Application (2027-2032) & (US$/Unit) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Pregabalin Distributors List Table 195. Pregabalin Customers List Table 196. Pregabalin Industry Trends Table 197. Pregabalin Industry Drivers Table 198. Pregabalin Industry Restraints Table 199. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Pregabalin Product Image Figure 5. Global Pregabalin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Pregabalin Market Size (2021-2032) & (US$ Million) Figure 7. Global Pregabalin Sales (2021-2032) & (W Units) Figure 8. Global Pregabalin Average Price (US$/Unit) & (2021-2032) Figure 9. Capsule Product Image Figure 10. Oral Solution Product Image Figure 11. Tablet Product Image Figure 12. Hospitals Product Image Figure 13. Clinics Product Image Figure 14. Others Product Image Figure 15. Global Pregabalin Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Pregabalin, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Pregabalin Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Pregabalin Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Pregabalin Sales by Region in 2025 Figure 21. Global Pregabalin Revenue by Region in 2025 Figure 22. North America Pregabalin Market Size by Country in 2025 Figure 23. North America Pregabalin Sales Market Share by Country (2021-2032) Figure 24. North America Pregabalin Revenue Market Share by Country (2021-2032) Figure 25. United States Pregabalin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Pregabalin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Pregabalin Market Size by Country in 2025 Figure 28. Europe Pregabalin Sales Market Share by Country (2021-2032) Figure 29. Europe Pregabalin Revenue Market Share by Country (2021-2032) Figure 30. Germany Pregabalin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Pregabalin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Pregabalin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Pregabalin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Netherlands Pregabalin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Nordic Countries Pregabalin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Asia Pacific Pregabalin Market Size by Country in 2025 Figure 37. Asia Pacific Pregabalin Sales Market Share by Country (2021-2032) Figure 38. Asia Pacific Pregabalin Revenue Market Share by Country (2021-2032) Figure 39. China Pregabalin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Japan Pregabalin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. South Korea Pregabalin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. India Pregabalin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Australia Pregabalin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. China Taiwan Pregabalin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Southeast Asia Pregabalin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Southeast Asia Pregabalin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South America Pregabalin Market Size by Country in 2025 Figure 48. South America Pregabalin Sales Market Share by Country (2021-2032) Figure 49. South America Pregabalin Revenue Market Share by Country (2021-2032) Figure 50. Mexico Pregabalin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Brazil Pregabalin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Argentina Pregabalin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Colombia Pregabalin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Middle East and Africa Pregabalin Market Size by Country in 2025 Figure 55. Middle East and Africa Pregabalin Sales Market Share by Country (2021-2032) Figure 56. Middle East and Africa Pregabalin Revenue Market Share by Country (2021-2032) Figure 57. Turkey Pregabalin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Pregabalin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. UAE Pregabalin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Global Pregabalin Sales Market Share by Type (2021-2032) Figure 61. Global Pregabalin Revenue Market Share by Type (2021-2032) Figure 62. Global Pregabalin Price (US$/Unit) by Type (2021-2032) Figure 63. Global Pregabalin Sales Market Share by Application (2021-2032) Figure 64. Global Pregabalin Revenue Market Share by Application (2021-2032) Figure 65. Global Pregabalin Price (US$/Unit) by Application (2021-2032) Figure 66. Pregabalin Value Chain Figure 67. Pregabalin Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Pregabalin Industry Opportunities and Challenges

Scope & coverage.

Types
  • Capsule
  • Oral Solution
  • Tablet
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Zhejiang Huahai Pharmaceutical
  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical Industries
  • Changzhou Pharmaceutical Factory (CPF)
  • ZCL Chemicals
  • Vasudha Pharma Chem
  • Srini Pharmaceuticals
  • Olon S.p.A.
  • Maps Laboratories
  • Laurus Labs
  • Hikal
  • Glenmark Life Sciences
  • Dongbang FTL
  • Divi’s Laboratories
  • Divi’s Laboratories
  • CTX Life Sciences
  • Chemo Iberica
  • Bazayan
  • BAL Pharma
  • Aurobindo Pharma
  • ARITE Pharmaceutical
  • Angels Pharma
  • Almelo Pvt. Ltd.
  • AASraw Biochemical Technology

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Pregabalin Market Size (2021-2032)
  4. 2.2.2 Global Pregabalin Sales (2021-2032)
  5. 2.2.3 Global Pregabalin Market Average Price (2021-2032)
  6. 2.3 Pregabalin by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Capsule
  9. 2.3.3 Oral Solution
  10. 2.3.4 Tablet
  11. 2.4 Pregabalin by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Hospitals
  14. 2.4.3 Clinics
  15. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Pregabalin Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Pregabalin Sales (W Units) of Manufacturers (2021-2026)
  3. 3.3 Global Pregabalin Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Pregabalin Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Pregabalin Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Pregabalin, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Pregabalin, Product Type & Application
  8. 3.8 Global Manufacturers of Pregabalin, Established Date
  9. 3.9 Global Pregabalin Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Zhejiang Huahai Pharmaceutical
  2. 4.1.1 Zhejiang Huahai Pharmaceutical Company Information
  3. 4.1.2 Zhejiang Huahai Pharmaceutical Business Overview
  4. 4.1.3 Zhejiang Huahai Pharmaceutical Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Zhejiang Huahai Pharmaceutical Pregabalin Product Portfolio
  6. 4.1.5 Zhejiang Huahai Pharmaceutical Recent Developments
  7. 4.2 Teva Pharmaceutical Industries
  8. 4.2.1 Teva Pharmaceutical Industries Company Information
  9. 4.2.2 Teva Pharmaceutical Industries Business Overview
  10. 4.2.3 Teva Pharmaceutical Industries Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Teva Pharmaceutical Industries Pregabalin Product Portfolio
  12. 4.2.5 Teva Pharmaceutical Industries Recent Developments
  13. 4.3 Sun Pharmaceutical Industries
  14. 4.3.1 Sun Pharmaceutical Industries Company Information
  15. 4.3.2 Sun Pharmaceutical Industries Business Overview
  16. 4.3.3 Sun Pharmaceutical Industries Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Sun Pharmaceutical Industries Pregabalin Product Portfolio
  18. 4.3.5 Sun Pharmaceutical Industries Recent Developments
  19. 4.4 Changzhou Pharmaceutical Factory (CPF)
  20. 4.4.1 Changzhou Pharmaceutical Factory (CPF) Company Information
  21. 4.4.2 Changzhou Pharmaceutical Factory (CPF) Business Overview
  22. 4.4.3 Changzhou Pharmaceutical Factory (CPF) Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Changzhou Pharmaceutical Factory (CPF) Pregabalin Product Portfolio
  24. 4.4.5 Changzhou Pharmaceutical Factory (CPF) Recent Developments
  25. 4.5 ZCL Chemicals
  26. 4.5.1 ZCL Chemicals Company Information
  27. 4.5.2 ZCL Chemicals Business Overview
  28. 4.5.3 ZCL Chemicals Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 ZCL Chemicals Pregabalin Product Portfolio
  30. 4.5.5 ZCL Chemicals Recent Developments
  31. 4.6 Vasudha Pharma Chem
  32. 4.6.1 Vasudha Pharma Chem Company Information
  33. 4.6.2 Vasudha Pharma Chem Business Overview
  34. 4.6.3 Vasudha Pharma Chem Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Vasudha Pharma Chem Pregabalin Product Portfolio
  36. 4.6.5 Vasudha Pharma Chem Recent Developments
  37. 4.7 Srini Pharmaceuticals
  38. 4.7.1 Srini Pharmaceuticals Company Information
  39. 4.7.2 Srini Pharmaceuticals Business Overview
  40. 4.7.3 Srini Pharmaceuticals Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Srini Pharmaceuticals Pregabalin Product Portfolio
  42. 4.7.5 Srini Pharmaceuticals Recent Developments
  43. 4.8 Olon S.p.A.
  44. 4.8.1 Olon S.p.A. Company Information
  45. 4.8.2 Olon S.p.A. Business Overview
  46. 4.8.3 Olon S.p.A. Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Olon S.p.A. Pregabalin Product Portfolio
  48. 4.8.5 Olon S.p.A. Recent Developments
  49. 4.9 Maps Laboratories
  50. 4.9.1 Maps Laboratories Company Information
  51. 4.9.2 Maps Laboratories Business Overview
  52. 4.9.3 Maps Laboratories Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Maps Laboratories Pregabalin Product Portfolio
  54. 4.9.5 Maps Laboratories Recent Developments
  55. 4.10 Laurus Labs
  56. 4.10.1 Laurus Labs Company Information
  57. 4.10.2 Laurus Labs Business Overview
  58. 4.10.3 Laurus Labs Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Laurus Labs Pregabalin Product Portfolio
  60. 4.10.5 Laurus Labs Recent Developments
  61. 4.11 Hikal
  62. 4.11.1 Hikal Company Information
  63. 4.11.2 Hikal Business Overview
  64. 4.11.3 Hikal Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Hikal Pregabalin Product Portfolio
  66. 4.11.5 Hikal Recent Developments
  67. 4.12 Glenmark Life Sciences
  68. 4.12.1 Glenmark Life Sciences Company Information
  69. 4.12.2 Glenmark Life Sciences Business Overview
  70. 4.12.3 Glenmark Life Sciences Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Glenmark Life Sciences Pregabalin Product Portfolio
  72. 4.12.5 Glenmark Life Sciences Recent Developments
  73. 4.13 Dongbang FTL
  74. 4.13.1 Dongbang FTL Company Information
  75. 4.13.2 Dongbang FTL Business Overview
  76. 4.13.3 Dongbang FTL Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Dongbang FTL Pregabalin Product Portfolio
  78. 4.13.5 Dongbang FTL Recent Developments
  79. 4.14 Divi’s Laboratories
  80. 4.14.1 Divi’s Laboratories Company Information
  81. 4.14.2 Divi’s Laboratories Business Overview
  82. 4.14.3 Divi’s Laboratories Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Divi’s Laboratories Pregabalin Product Portfolio
  84. 4.14.5 Divi’s Laboratories Recent Developments
  85. 4.15 Divi’s Laboratories
  86. 4.15.1 Divi’s Laboratories Company Information
  87. 4.15.2 Divi’s Laboratories Business Overview
  88. 4.15.3 Divi’s Laboratories Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Divi’s Laboratories Pregabalin Product Portfolio
  90. 4.15.5 Divi’s Laboratories Recent Developments
  91. 4.16 CTX Life Sciences
  92. 4.16.1 CTX Life Sciences Company Information
  93. 4.16.2 CTX Life Sciences Business Overview
  94. 4.16.3 CTX Life Sciences Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 CTX Life Sciences Pregabalin Product Portfolio
  96. 4.16.5 CTX Life Sciences Recent Developments
  97. 4.17 Chemo Iberica
  98. 4.17.1 Chemo Iberica Company Information
  99. 4.17.2 Chemo Iberica Business Overview
  100. 4.17.3 Chemo Iberica Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Chemo Iberica Pregabalin Product Portfolio
  102. 4.17.5 Chemo Iberica Recent Developments
  103. 4.18 Bazayan
  104. 4.18.1 Bazayan Company Information
  105. 4.18.2 Bazayan Business Overview
  106. 4.18.3 Bazayan Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Bazayan Pregabalin Product Portfolio
  108. 4.18.5 Bazayan Recent Developments
  109. 4.19 BAL Pharma
  110. 4.19.1 BAL Pharma Company Information
  111. 4.19.2 BAL Pharma Business Overview
  112. 4.19.3 BAL Pharma Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 BAL Pharma Pregabalin Product Portfolio
  114. 4.19.5 BAL Pharma Recent Developments
  115. 4.20 Aurobindo Pharma
  116. 4.20.1 Aurobindo Pharma Company Information
  117. 4.20.2 Aurobindo Pharma Business Overview
  118. 4.20.3 Aurobindo Pharma Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Aurobindo Pharma Pregabalin Product Portfolio
  120. 4.20.5 Aurobindo Pharma Recent Developments
  121. 4.21 ARITE Pharmaceutical
  122. 4.21.1 ARITE Pharmaceutical Company Information
  123. 4.21.2 ARITE Pharmaceutical Business Overview
  124. 4.21.3 ARITE Pharmaceutical Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 ARITE Pharmaceutical Pregabalin Product Portfolio
  126. 4.21.5 ARITE Pharmaceutical Recent Developments
  127. 4.22 Angels Pharma
  128. 4.22.1 Angels Pharma Company Information
  129. 4.22.2 Angels Pharma Business Overview
  130. 4.22.3 Angels Pharma Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Angels Pharma Pregabalin Product Portfolio
  132. 4.22.5 Angels Pharma Recent Developments
  133. 4.23 Almelo Pvt. Ltd.
  134. 4.23.1 Almelo Pvt. Ltd. Company Information
  135. 4.23.2 Almelo Pvt. Ltd. Business Overview
  136. 4.23.3 Almelo Pvt. Ltd. Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Almelo Pvt. Ltd. Pregabalin Product Portfolio
  138. 4.23.5 Almelo Pvt. Ltd. Recent Developments
  139. 4.24 AASraw Biochemical Technology
  140. 4.24.1 AASraw Biochemical Technology Company Information
  141. 4.24.2 AASraw Biochemical Technology Business Overview
  142. 4.24.3 AASraw Biochemical Technology Pregabalin Sales, Revenue and Gross Margin (2021-2026)
  143. 4.24.4 AASraw Biochemical Technology Pregabalin Product Portfolio
  144. 4.24.5 AASraw Biochemical Technology Recent Developments
5 Global Pregabalin Market Scenario by Region
  1. 5.1 Global Pregabalin Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Pregabalin Sales by Region: 2021-2032
  3. 5.2.1 Global Pregabalin Sales by Region: 2021-2026
  4. 5.2.2 Global Pregabalin Sales by Region: 2027-2032
  5. 5.3 Global Pregabalin Revenue by Region: 2021-2032
  6. 5.3.1 Global Pregabalin Revenue by Region: 2021-2026
  7. 5.3.2 Global Pregabalin Revenue by Region: 2027-2032
  8. 5.4 North America Pregabalin Market Facts & Figures by Country
  9. 5.4.1 North America Pregabalin Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Pregabalin Sales by Country (2021-2032)
  11. 5.4.3 North America Pregabalin Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Pregabalin Market Facts & Figures by Country
  15. 5.5.1 Europe Pregabalin Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Pregabalin Sales by Country (2021-2032)
  17. 5.5.3 Europe Pregabalin Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.5.9 Nordic Countries
  24. 5.6 Asia Pacific Pregabalin Market Facts & Figures by Country
  25. 5.6.1 Asia Pacific Pregabalin Market Size by Country: 2021 VS 2025 VS 2032
  26. 5.6.2 Asia Pacific Pregabalin Sales by Country (2021-2032)
  27. 5.6.3 Asia Pacific Pregabalin Revenue by Country (2021-2032)
  28. 5.6.4 China
  29. 5.6.5 Japan
  30. 5.6.6 South Korea
  31. 5.6.7 India
  32. 5.6.8 Australia
  33. 5.6.9 China Taiwan
  34. 5.6.10 Southeast Asia
  35. 5.7 South America Pregabalin Market Facts & Figures by Country
  36. 5.7.1 South America Pregabalin Market Size by Country: 2021 VS 2025 VS 2032
  37. 5.7.2 South America Pregabalin Sales by Country (2021-2032)
  38. 5.7.3 South America Pregabalin Revenue by Country (2021-2032)
  39. 5.7.4 Mexico
  40. 5.7.5 Brazil
  41. 5.7.6 Argentina
  42. 5.7.7 Colombia
  43. 5.8 Middle East and Africa Pregabalin Market Facts & Figures by Country
  44. 5.8.1 Middle East and Africa Pregabalin Market Size by Country: 2021 VS 2025 VS 2032
  45. 5.8.2 Middle East and Africa Pregabalin Sales by Country (2021-2032)
  46. 5.8.3 Middle East and Africa Pregabalin Revenue by Country (2021-2032)
  47. 5.8.4 Turkey
  48. 5.8.5 Saudi Arabia
  49. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Pregabalin Sales by Type (2021-2032)
  2. 6.1.1 Global Pregabalin Sales by Type (2021-2032) & (W Units)
  3. 6.1.2 Global Pregabalin Sales Market Share by Type (2021-2032)
  4. 6.2 Global Pregabalin Revenue by Type (2021-2032)
  5. 6.2.1 Global Pregabalin Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Pregabalin Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Pregabalin Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Pregabalin Sales by Application (2021-2032)
  2. 7.1.1 Global Pregabalin Sales by Application (2021-2032) & (W Units)
  3. 7.1.2 Global Pregabalin Sales Market Share by Application (2021-2032)
  4. 7.2 Global Pregabalin Revenue by Application (2021-2032)
  5. 7.2.1 Global Pregabalin Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Pregabalin Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Pregabalin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Pregabalin Value Chain Analysis
  2. 8.1.1 Pregabalin Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Pregabalin Production Mode & Process
  5. 8.2 Pregabalin Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Pregabalin Distributors
  8. 8.2.3 Pregabalin Customers
9 Global Pregabalin Analyzing Market Dynamics
  1. 9.1 Pregabalin Industry Trends
  2. 9.2 Pregabalin Industry Drivers
  3. 9.3 Pregabalin Industry Opportunities and Challenges
  4. 9.4 Pregabalin Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst